Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

Overview of attention for article published in Retrovirology, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 87 Dimensions

Readers on

mendeley: 91 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 2,314 followers.

Note on genetic barrier to resistance for InSTIs: RAL > EVG > CAB > DTG and BIC. https://t.co/DRCzo8tYCX

10 Mar 2021

Reply Repost Favourite

Of the currently available integrase strand transfer inhibitors (INSTIs), dolutegravir and bictegravir show the highest barriers to resistance. #OTILT @TaehyeonKim13 @BWDionne @jeffpears0n https://t.co/MMi62fPEY8

18 Sep 2020

Reply Repost Favourite

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir https://t.co/9Q2UtUFhSv

27 Aug 2018

Reply Repost Favourite

#retrovirology Selective resistance profiles emerging in patient-derived clinical isolates… https://t.co/ihnYl2rAj9

18 Aug 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.